TTM
$6.03
YoY change
+10.1%
5Y CAGR
+12.0%
Peak year (2025)
$6.02
Latest annual
$6.02
EPS (Diluted) history chart for Zoetis (ZTS) from 2009 to 2025
Latest: $6.02
EPS (Diluted) growth chart for Zoetis (ZTS) from 2009 to 2025
Latest: +10.1%
EPS (Diluted) history table for Zoetis (ZTS) from 2009 to 2025
| 2025 | $6.02 | +10.1% | +$0.55 | ||
| 2024 | $5.47 | +7.9% | +$0.40 | ||
| 2023 | $5.07 | +12.9% | +$0.58 | ||
| 2022 | $4.49 | +5.2% | +$0.22 | ||
| 2021 | $4.27 | +24.9% | +$0.85 | ||
| 2020 | $3.42 | +10.0% | +$0.31 | ||
| 2019 | $3.11 | +6.1% | +$0.18 | ||
| 2018 | $2.93 | +67.4% | +$1.18 | ||
| 2017 | $1.75 | +6.1% | +$0.10 | ||
| 2016 | $1.65 | +142.6% | +$0.97 | ||
| 2015 | $0.68 | -41.4% | −$0.48 | ||
| 2014 | $1.16 | +14.9% | +$0.15 | ||
| 2013 | $1.01 | +16.1% | +$0.14 | ||
| 2012 | $0.87 | +70.6% | +$0.36 | ||
| 2011 | $0.51 | +121.7% | +$0.28 | ||
| 2010 | $0.23 | -209.5% | +$0.44 | ||
| 2009 | −$0.21 | — | — |
- 2025$6.02+10.1%
- 2024$5.47+7.9%
- 2023$5.07+12.9%
- 2022$4.49+5.2%
- 2021$4.27+24.9%
- 2020$3.42+10.0%
- 2019$3.11+6.1%
- 2018$2.93+67.4%
- 2017$1.75+6.1%
- 2016$1.65+142.6%
- 2015$0.68-41.4%
- 2014$1.16+14.9%
- 2013$1.01+16.1%
- 2012$0.87+70.6%
- 2011$0.51+121.7%
- 2010$0.23-209.5%
- 2009−$0.21—
EPS (Diluted) values are taken from Zoetis's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Zoetis (ZTS)
According to Zoetis's latest reported financial statements, the company's current diluted EPS (TTM) is $6.03. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Zoetis (ZTS) most recent annual diluted EPS stands at $6.02 (2025) – grew 10.1% year-over-year.
Zoetis diluted EPS compound annual growth for the 2020–2025 (5 years) window is +12.0%, sustaining 10 straight years of year-over-year growth.
The record annual diluted EPS stands at $6.02, reached in 2025; the historical low of −$0.21 was recorded in 2009.
Zoetis EPS (Diluted) by Year
Zoetis EPS (Diluted) 2025: $6.02
2025's diluted EPS for Zoetis came in at $6.02, grew 10.1% from 2024. This figure represents the highest annual value in the available history.
Zoetis EPS (Diluted) 2024: $5.47
Zoetis posted diluted EPS of $5.47 in 2024, grew 7.9% from 2023.
Zoetis EPS (Diluted) 2023: $5.07
In 2023, Zoetis reported diluted EPS of $5.07, grew 12.9% from 2022.
Zoetis EPS (Diluted) 2022: $4.49
Zoetis diluted EPS in 2022 was $4.49, grew 5.2% from 2021.
Zoetis EPS (Diluted) 2021: $4.27
Zoetis diluted EPS in 2021 was $4.27.
See more financial history for Zoetis (ZTS). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Zoetis (ZTS), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Zoetis (ZTS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation